Chronic myeloid leukemia (CML) is a rare blood cancer that develops in the bone marrow. Karyotyping is a genetic technique doctors use to diagnose CML and choose more effective treatments. Karyotyping ...
Phase I/II study of idarubicin (Ida), high-dose ara-C, and sorafenib (S) in patients (pts) younger than 65 years with acute myeloid leukemia (AML) ...
Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...
You have full access to this article via your institution. We captured images with video/CCD cameras or a digital camera (DP-10, Olympus), replacing the 'classic' film cameras mounted on older-model ...
Neuberg Sehgal Path Lab, a leading name in diagnostic services, launched a cutting-edge cytogenetics testing technology at ...
Cell free DNA screening vs direct invasive procedures for detection of trisomy 21. For women with pregnancies at high risk for trisomy 21, performing cell-free DNA tests over direct invasive ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 68, No. 4 (Apr., 1971), pp. 726-730 (5 pages) Human chromosomes from cultures of peripheral lymphocytes were ...
Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors. This ...
Life sciences company Bionano (BNGO) has drawn a lot of attention this year due its potential to disrupt the cytogenetics field - the study of chromosomes. Bionano’s optical genome mapping (OGM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results